Skip to content

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

Predictability of Carcinomatous Invasion of the Maxilla or Mandible: An Assessment of Radiologic Modalities With Histologic Correlation

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03053960
Enrollment
8
Registered
2017-02-15
Start date
2015-11-24
Completion date
2018-11-01
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cavity Squamous Cell Carcinoma

Brief summary

This clinical trial studies how well helical computed tomography (CT), positron emission tomography (PET)/CT, magnetic resonance imaging (MRI), and cone beam computed tomography (CBCT) work alone or in combination in predicting whether tumor cells have spread to the jaw bone (jaw invasion) in patients with oral cancer. Imaging, such as helical CT, PET/CT, MRI, and CBCT, may help find out how far cancer has spread. Accurate prediction of the presence or absence of jaw invasion may help create a better surgical treatment plan for patients with oral cancer.

Detailed description

PRIMARY OBJECTIVES: I. To determine which imaging modality or combination of imaging methods, in conjunction with clinical and histological examination, will most accurately predict the presence or absence of invasion of the mandible or maxilla by intraoral squamous cell carcinoma (SCC). SECONDARY OBJECTIVES: I. To compare the histopathologic findings to the radiologic findings.

Interventions

DEVICEComputed Tomography

Undergo helical CT scan

DEVICECone-Beam Computed Tomography

Undergo CBCT scan

DEVICEMagnetic Resonance Imaging

Undergo MRI scan

PROCEDURETherapeutic Conventional Surgery

Undergo resection of tumor

Correlative studies

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of squamous cell carcinoma of the oral cavity * Able to read and sign and informed consent

Exclusion criteria

* Prior mandibular surgery * Primary intraosseous carcinoma * Prior history of radiation to the mandible * Obvious finding of clinical invasion of the mandible

Design outcomes

Primary

MeasureTime frameDescription
Accurate Predication of the Presence or Absence of Bone Invasion by Oral Squamous Cell Carcinoma by Helical CT, PET/CT, MRI and CBCTUp to 2 yearsSensitivity and specificity of the clinical exam, CBCT, helical CT, PET/CT, MRI and any other imaging modality used in detection of bone invasion will be calculated, as compared to the histological examination of the specimens. The positive and negative predictive value will be calculated for each modality using the true positive and negatives as well as false positive and negative values

Secondary

MeasureTime frame
Incidence of Sparing ResectionUp to 2 years

Participant flow

Participants by arm

ArmCount
Diagnostic (Helical CT, PET/CT, MRI, CBCT)
Patients undergo helical (Computed Tomography) CT,(Positron Emission Tomography and Computed Tomography) PET/CT, (Magnetic Resonance Imaging) MRI, and (Cone-Beam Computed Tomography) CBCT scans. Patients also undergo therapeutic conventional surgical resection of tumor. Computed Tomography: Undergo helical CT scan Positron Emission Tomography and Computed Tomography Scan: Undergo PET/CT scan Cone-Beam Computed Tomography: Undergo CBCT scan Magnetic Resonance Imaging: Undergo MRI scan Therapeutic Conventional Surgery: Undergo resection of tumor Histopathologic Examination: Correlative studies
8
Total8

Baseline characteristics

CharacteristicDiagnostic (Helical CT, PET/CT, MRI, CBCT)
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
7 Participants
Region of Enrollment
United States
8 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 8
other
Total, other adverse events
0 / 8
serious
Total, serious adverse events
0 / 8

Outcome results

Primary

Accurate Predication of the Presence or Absence of Bone Invasion by Oral Squamous Cell Carcinoma by Helical CT, PET/CT, MRI and CBCT

Sensitivity and specificity of the clinical exam, CBCT, helical CT, PET/CT, MRI and any other imaging modality used in detection of bone invasion will be calculated, as compared to the histological examination of the specimens. The positive and negative predictive value will be calculated for each modality using the true positive and negatives as well as false positive and negative values

Time frame: Up to 2 years

Population: The study was terminated by the IRB. Sincere efforts were made to gather and report the data, however, no data is available for the study.

Secondary

Incidence of Sparing Resection

Time frame: Up to 2 years

Population: The study was terminated by the IRB. Sincere efforts were made to gather and report the data, however, no data is available for the study.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026